1 – 10 of 122
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes
(
- Contribution to journal › Article
-
Mark
Similar immune responses to alpha1-oleate and Bacillus Calmette–Guérin treatment in patients with bladder cancer
(
- Contribution to journal › Article
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
(
- Contribution to journal › Article
- 2023
-
Mark
The current use of the EORTC QLQ-NMIBC24 and QLQ-BLM30 questionnaires for the assessment of health-related quality of life in bladder cancer patients : a systematic review
(
- Contribution to journal › Scientific review
-
Mark
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
(
- Contribution to journal › Article
-
Mark
Quality of Life in Patients with High-grade Non–muscle-invasive Bladder Cancer Undergoing Standard Versus Reduced Frequency of Bacillus Calmette-Guérin Instillations : The EAU-RF NIMBUS Trial
(
- Contribution to journal › Article
-
Mark
Women’s experience of sexuality after radical cystectomy–a qualitative study
(
- Contribution to journal › Article
-
Mark
FDG-PET/CT for lymph node staging prior to radical cystectomy
(
- Contribution to journal › Article
-
Mark
Long-term prevention of bladder cancer progression by alpha1-oleate alone or in combination with chemotherapy
(
- Contribution to journal › Article
-
Mark
Latent heterogeneity of muscle-invasive bladder cancer in patient characteristics and survival : A population-based nation-wide study in the Bladder Cancer Data Base Sweden (BladderBaSe)
(
- Contribution to journal › Article